0 CHECKOUT

PLx Pharma Inc. - Product Pipeline Review - 2015

  • ID: 3293082
  • May 2015
  • 29 pages
  • Global Markets Direct
1 of 3

PLx Pharma Inc. - Product Pipeline Review - 2015

Summary

This, ‘PLx Pharma Inc. - Product Pipeline Review - 2015’, provides an overview of the PLx Pharma Inc.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of PLx Pharma Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

This report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from This proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by This team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes READ MORE >

Note: Product cover images may vary from those shown
2 of 3

List of Tables
List of Figures
PLx Pharma Inc. Snapshot
PLx Pharma Inc. Overview
Key Information
Key Facts
PLx Pharma Inc. - Research and Development Overview
Key Therapeutic Areas
PLx Pharma Inc. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
PLx Pharma Inc. - Pipeline Products Glance
PLx Pharma Inc. - Late Stage Pipeline Products
Phase III Products/Combination Treatment Modalities
PLx Pharma Inc. - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
PLx Pharma Inc. - Drug Profiles
aspirin
Product Description
Mechanism of Action
R&D Progress
Diclofenac-PC
Product Description
Mechanism of Action
R&D Progress
Ketorolac-PC
Product Description
Mechanism of Action
R&D Progress
PL-1100
Product Description
Mechanism of Action
R&D Progress
PL-4100
Product Description
Mechanism of Action
R&D Progress
PL-4500
Product Description
Mechanism of Action
R&D Progress
PL-5100
Product Description
Mechanism of Action
R&D Progress
PLx Pharma Inc. - Pipeline Analysis
PLx Pharma Inc. - Pipeline Products by Target
PLx Pharma Inc. - Pipeline Products by Route of Administration
PLx Pharma Inc. - Pipeline Products by Molecule Type
PLx Pharma Inc. - Pipeline Products by Mechanism of Action
PLx Pharma Inc. - Recent Pipeline Updates
PLx Pharma Inc. - Dormant Projects
PLx Pharma Inc. - Locations And Subsidiaries
Head Office
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
PLx Pharma Inc., Key Information
PLx Pharma Inc., Key Facts
PLx Pharma Inc. - Pipeline by Indication, 2015
PLx Pharma Inc. - Pipeline by Stage of Development, 2015
PLx Pharma Inc. - Monotherapy Products in Pipeline, 2015
PLx Pharma Inc. - Phase III, 2015
PLx Pharma Inc. - Preclinical, 2015
PLx Pharma Inc. - Discovery, 2015
PLx Pharma Inc. - Pipeline by Target, 2015
PLx Pharma Inc. - Pipeline by Route of Administration, 2015
PLx Pharma Inc. - Pipeline by Molecule Type, 2015
PLx Pharma Inc. - Pipeline Products by Mechanism of Action, 2015
PLx Pharma Inc. - Recent Pipeline Updates, 2015
PLx Pharma Inc. - Dormant Developmental Projects,2015

List of Figures
PLx Pharma Inc. - Pipeline by Top 10 Indication, 2015
PLx Pharma Inc. - Pipeline by Stage of Development, 2015
PLx Pharma Inc. - Monotherapy Products in Pipeline, 2015
PLx Pharma Inc. - Pipeline by Top 10 Target, 2015
PLx Pharma Inc. - Pipeline by Top 10 Route of Administration, 2015
PLx Pharma Inc. - Pipeline by Top 10 Molecule Type, 2015
PLx Pharma Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown

PURCHASING OPTIONS

HAVE A QUESTION?

EMAIL US VIEW FAQs

RELATED PRODUCTS from Db

Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.